Dr. Michael Mithoefer is a psychiatrist and psychotherapist who has been pivotal in the field of MDMA-assisted psychotherapy for PTSD. Working closely with the Multidisciplinary Association for Psychedelic Studies (MAPS), he has been at the forefront of clinical research into MDMA's therapeutic potential since the early 2000s. Along with his wife, Annie Mithoefer, he has trained countless therapists across the globe and helped establish the rigorous protocols for MDMA-assisted therapy.

In recent years, Mithoefer's work on MDMA for PTSD has gained international recognition. His clinical trials have paved the way for MDMA to be considered for FDA approval, potentially transforming the landscape of trauma treatment worldwide. This landmark research is expected to set a global precedent for countries interested in adopting psychedelic-assisted therapies in mental health care. With a long-term vision, Mithoefer and his colleagues are dedicated to creating more accessible therapeutic approaches for trauma survivors.

Michael Mithoefer is not only a great researcher but also a deeply compassionate therapist who exemplifies the healing potential of psychedelics in therapy.